https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=4
GLS™ Versaflex™ Thermoplastic Elastomer provided the right balance of haptics and fulfilled healthcare regulations
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=31
Dynaflex™ TPE delivers the right support, look and feel for leading seating manufacturer's lumbar support
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=43
This video explores how the new Avient.com can help users explore new ideas and find just the right solution.
https://www.avient.com/resource-center?document_type=59&page=43
This video explores how the new Avient.com can help users explore new ideas and find just the right solution.
https://www.avient.com/knowledge-base/article/processing-styrenic-block-copolymer-tpes-gls?rtype[]=1164
As the industry leader in soft tactile grip thermoplastic elastomers, GLS can suggest the right hardness to meet your most demanding applications.
https://www.avient.com/knowledge-base/article/exploring-world-fluoropolymers?ind[]=21509
Selecting the right fluoropolymer for your application can have multiple nuances, from properties and processing to design and appearance.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for France.pdf
Buyer shall have no right of set-off.
Buyer assumes all risks and liabilities (i) arising out of unloading, discharge, storage, handling and use of the Product, or
(ii) arising out of compliance or non-compliance with laws and regulations governing or controlling such activity.
Rights of Third Parties.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Annual%2520Report.pdf
Cash provided by (used by):
Operating Activities $ 202.4 $ 227.6 $ 240.3
Investing Activities (119.4) (235.4) (106.5)
Financing Activities (72.7) (40.3) (83.5)
Effect of exchange rate on cash 6.6 (5.0) (9.1)
Net increase (decrease) in cash and cash equivalents $ 16.9 $ (53.1) $ 41.2
Operating activities
In 2017, net cash provided by operating activities was $202.4 million as compared to $227.6 million in 2016.
Restricted Stock Units
RSUs represent contingent rights to receive one common share at a future date provided certain vesting criteria are
met.
Nominating & Governance
* Denotes Chairperson
PolyOne Corporation Board of Directors (Left to Right): William A.
https://www.avient.com/sites/default/files/2024-03/AS-FILED EF20024640 Avient Corp ARS.pdf
Cash Flows
The following table summarizes our cash flows from operating, investing and financing activities:
Cash provided by (used by):
Operating Activities $ 201.6 $ 398.4 $ 233.8
Investing Activities (94.2) (504.0) (150.2)
Financing Activities (201.7) 166.4 (114.6)
Effect of exchange rate on cash (1.0) (20.9) (17.3)
Net (decrease) increase in cash and cash equivalents $ (95.3) $ 39.9 $ (48.3)
Operating Activities
In 2023, net cash provided by operating activities decreased to $201.6 million as compared to $398.4 million in
2022, driven primarily by lower earnings and taxes paid associated with the sale of the Distribution business,
partially offset by a decrease in working capital.
Restricted Stock Units
RSUs represent contingent rights to receive one common share at a future date provided certain vesting criteria are
met.
Only a portion of these shares may be issued with respect to awards other than options,
warrants and rights.
https://www.avient.com/sites/default/files/resources/PolyOne%25202013%2520Annual%2520Report.pdf
Cash provided by (used in):
Operating Activities $109.0 $106.9 $ 72.5
Investing Activities (60.1) (72.3) (422.5)
Financing Activities 104.8 (17.5) 163.9
Effect of exchange rate on cash 1.5 1.0 (0.1)
Net increase (decrease) in cash and cash equivalents $155.2 $ 18.1 $(186.2)
Operating activities
In 2013, net cash provided by operating activities was $109.0 million as compared to $106.9 million in
2012.
Investing Activities
Net cash used by investing activities during 2013 of $60.1 million primarily reflects our acquisition of
Spartech for $258.8 million, net of cash acquired, and capital expenditures of $76.4 million.
THIS PAGE IS NOT PART OF POLYONE’S FORM 10-K FILING
PolyOne Corporation Board of Directors (Left to Right): Sandra B.